Stoke Therapeutics Inc. (STOK) Social Stream



Stoke Therapeutics Inc. (STOK): $23.65

-1.59 (-6.30%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add STOK to Watchlist
Sign Up

Industry: Biotech


Ranked

of 506

in industry

Stoke Therapeutics Inc (STOK) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering STOK.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
8 $83 $35 $62.88 $25.18 149.72%

The Trend in the Analyst Price Target


Over the past 16 months, STOK's average price target has gone up $25.48.

Over the past 16 months, STOK's average upside potential has been 53.34%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-04 8 83 35 62.88 25.35 148.05%
2021-08-28 8 83 35 62.88 27.07 132.29%
2021-08-14 8 83 35 63.88 25.73 148.27%
2021-08-07 8 83 35 63.75 26.16 143.69%
2021-08-05 8 83 35 63.75 26.82 137.7%
2021-08-01 8 83 35 63.75 28.63 122.67%
2021-07-24 8 83 35 63.75 30.66 107.93%
2021-07-17 8 83 35 63.75 33.35 91.15%
2021-07-10 8 83 35 63.75 34.27 86.02%
2021-07-03 8 83 35 63.75 33.78 88.72%
2021-06-26 8 83 35 63.75 34.26 86.08%
2021-06-13 8 83 35 63.75 37.71 69.05%
2021-06-05 8 83 35 63.75 37.30 70.91%
2021-05-22 8 83 35 63.75 37.12 71.74%
2021-05-15 7 83 47 67.86 35.68 90.19%
2021-05-08 7 83 53 68.71 32.46 111.68%
2021-04-25 7 83 53 68.71 31.58 117.57%
2021-04-17 7 83 53 68.71 30.91 122.29%
2021-04-10 7 83 53 68.71 34.35 100.03%
2021-04-03 7 83 53 68.71 39.33 74.7%
2021-03-20 8 83 42 65.38 47.90 36.49%
2021-03-13 8 83 42 65.38 51.26 27.55%
2021-03-06 8 83 42 60.38 54.01 11.79%
2021-02-27 8 83 42 60.38 59.89 0.82%
2021-02-20 8 83 42 60.38 60.86 -0.79%
2021-02-13 8 83 42 60.38 59.93 0.75%
2021-02-06 8 83 42 59.50 63.07 -5.66%
2021-01-30 8 83 42 59.50 61.08 -2.59%
2021-01-23 8 72 42 57.63 67.32 -14.39%
2021-01-16 8 72 42 57.63 66.57 -13.43%
2021-01-09 8 72 42 56.50 61.16 -7.62%
2021-01-02 8 72 42 56.50 61.93 -8.77%
2020-12-26 8 70 42 54.13 58.28 -7.12%
2020-12-19 8 70 42 54.13 60.57 -10.63%
2020-12-10 8 68 30 48.13 52.00 -7.44%
2020-12-07 8 68 30 48.13 49.08 -1.94%
2020-11-28 8 68 30 48.13 51.17 -5.94%
2020-11-12 8 68 30 48.12 44.16 8.97%
2020-10-24 8 49 30 41.50 40.17 3.31%
2020-09-28 7 49 30 38.29 34.93 9.62%
2020-08-10 5 49 30 38.40 NA NA%
2020-07-29 5 46 30 37.40 NA NA%
2020-05-15 5 46 30 37.40 NA NA%

STOK Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.45 3 5 2 0 0 10

The Trend in the Broker Recommendations


STOK's average broker recommendation rating improved by 0.1 over the prior 123 days.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for STOK as an investment opportunity.

  • Stoke Therapeutics Inc's variance in analysts' estimates is less than 10.05% of all US stocks.
  • STOK has a greater upside potential (average analyst target price relative to current price) than 88.03% of all US stocks.
  • The average analyst price target of STOK is higher than 85.15% of Pharmaceutical Products stocks.
  • Stoke Therapeutics Inc's number of analysts covering the stock is greater than 78.29% of Pharmaceutical Products stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Stoke Therapeutics Inc are HGEN, DCPH and OMER.

Make investment decisions regarding STOK using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7121 seconds.